Sudeepa Bhattacharyya

This study links medication use to distinct gut microbial features in anxiety and depression, showing antidepressants have a larger effect on microbiota than diagnoses.

The paper examines the association between bile acid levels and functional connectivity of the executive control and default mode networks in patients with major depression.

This study identifies associations between bile acid profiles and symptoms of depression and anxiety in MDD patients, finding higher anxiety correlates and treatment failure predictors.

The paper links indoxyl sulfate, a gut microbiome-derived metabolite, to anxiety symptoms and specific brain connectivity patterns in patients with depression.

The paper uses targeted metabolomics to analyze changes in acylcarnitines, amines, and lipids in response to citalopram/escitalopram treatment in MDD patients, identifying metabolic correlates of treatment response.

This study identifies metabolomic clusters associated with depressive symptom change and treatment response to CBT in MDD patients.

The paper investigates the association between triglyceride principal component scores and Alzheimer's disease biomarkers in the ADNI cohort, finding significant links with MCI, AD, and specific brain structures.

The paper identifies altered bile acid profiles in Alzheimer's disease, linking them to cognitive impairment and genetic variants through a large study.